Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  4,442 results for ""Etoposide""

Your Filters

Subject : hematopoietic stem cell transplantation
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Canadian cancer trials group LY.17: A randomized phase II study evaluating novel salvage therapy pre-autologous stem cell transplant in relapsed/refractory diffuse large B-cell lymphoma-outcome of rituximab-dose-intensive cyclophosphamide, etoposide, cisplatin (R-DICEP) versus R-GDP.

  • Authors : Stewart DA; Tom Baker Cancer Centre, University of Calgary, Calgary, Alberta, Canada.; Kuruvilla J

Subjects: Lymphoma, Large B-Cell, Diffuse*/Lymphoma, Large B-Cell, Diffuse*/Lymphoma, Large B-Cell, Diffuse*/therapy ; Lymphoma, Large B-Cell, Diffuse*/Lymphoma, Large B-Cell, Diffuse*/Lymphoma, Large B-Cell, Diffuse*/drug therapy ; Lymphoma, Large B-Cell, Diffuse*/Lymphoma, Large B-Cell, Diffuse*/Lymphoma, Large B-Cell, Diffuse*/mortality

  • Source: British journal of haematology [Br J Haematol] 2024 Sep; Vol. 205 (3), pp. 881-890. Date of Electronic Publication: 2024 May 27.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Clinical and safety outcomes of BeEAM (Bendamustine, Etoposide, Cytarabine, Melphalan) versus CEM (Carboplatin, Etoposide, Melphalan) in lymphoma patients as a conditioning regimen before autologous hematopoietic cell transplantation.

  • Authors : Eltelbanei MA; Senior Clinical Pharmacist in Hematology, Oncology, and Stem Cell Transplantation at International Medical Center (IMC) Hospital, Clinical pharmacy & pharmacy practice master candidate at Faculty of pharmacy, Damanhour University, Cairo, Egypt. .; El-Bassiouny NA

Subjects: Hematopoietic Stem Cell Transplantation*/Hematopoietic Stem Cell Transplantation*/Hematopoietic Stem Cell Transplantation*/methods ; Hematopoietic Stem Cell Transplantation*/Hematopoietic Stem Cell Transplantation*/Hematopoietic Stem Cell Transplantation*/adverse effects ; Cytarabine*/Cytarabine*/Cytarabine*/administration & dosage

  • Source: BMC cancer [BMC Cancer] 2024 Aug 13; Vol. 24 (1), pp. 1002. Date of Electronic Publication: 2024 Aug 13.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Prognostic differences between carmustine, etoposide, cytarabine and melphalan (BEAM) and carmustine, etoposide, cytarabine, melphalan and fludarabine (BEAMF) regimens before autologous stem cell transplantation plus chimeric antigen receptor T therapy in patients with refractory/relapsed B-cell non-Hodgkin-lymphoma.

  • Authors : Xin X; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.; Lin L

Subjects: Vidarabine*/Vidarabine*/Vidarabine*/*analogs & derivatives; Carmustine*/Carmustine*/Carmustine*/therapeutic use ; Carmustine*/Carmustine*/Carmustine*/administration & dosage BEAM regimen

  • Source: Cytotherapy [Cytotherapy] 2024 May; Vol. 26 (5), pp. 456-465. Date of Electronic Publication: 2024 Feb 19.Publisher: Elsevier Country of Publication: England NLM ID: 100895309 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-2566

Record details

Read More Add to Saved list
×
Academic Journal

Mitoxantrone-Based Novel Conditioning Regimen Leads to Great Survival Benefit in Peripheral T-Cell Lymphoma Compared to BEAM Regimen.

  • Authors : Zuo X; Department of Hematology, Huadong Hospital, Fudan University, Shanghai, China.; Qian W

Subjects: Mitoxantrone*/Mitoxantrone*/Mitoxantrone*/administration & dosage ; Mitoxantrone*/Mitoxantrone*/Mitoxantrone*/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/therapeutic use

  • Source: Cancer medicine [Cancer Med] 2024 Dec; Vol. 13 (23), pp. e70476.Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Evaluation of the effects of MCVAC conditioning regimen followed by autologous hematopoietic stem cell transplantation in patients with relapsed and refractory Hodgkin lymphoma: A single-institution retrospective study.

  • Authors : Naganuma K; Department of Hematology, Saitama Medical Center, Saitama Medical University, Saitama, Japan.; Takahashi Y

Subjects: Hodgkin Disease*/Hodgkin Disease*/Hodgkin Disease*/therapy ; Hodgkin Disease*/Hodgkin Disease*/Hodgkin Disease*/mortality ; Hematopoietic Stem Cell Transplantation*/Hematopoietic Stem Cell Transplantation*/Hematopoietic Stem Cell Transplantation*/methods

  • Source: Journal of clinical and experimental hematopathology : JCEH [J Clin Exp Hematop] 2024 Sep 28; Vol. 64 (3), pp. 177-182. Date of Electronic Publication: 2024 Jul 31.Publisher: Nihon Rinpa Mōnaikei Gakkai Country of Publication: Japan NLM ID: 101141257 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Yttrium-90 anti-CD25 BEAM conditioning for autologous hematopoietic cell transplantation in Peripheral T-cell lymphoma.

  • Authors : Zain J; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA.; Tsai NC

Subjects: Hematopoietic Stem Cell Transplantation*/Hematopoietic Stem Cell Transplantation*/Hematopoietic Stem Cell Transplantation*/methods ; Carmustine*/Carmustine*/Carmustine*/therapeutic use ; Carmustine*/Carmustine*/Carmustine*/administration & dosage

  • Source: Blood advances [Blood Adv] 2024 Sep 24; Vol. 8 (18), pp. 4812-4822.Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Intensified conditioning regimens with total marrow irradiation/etoposide/cyclophosphamide and busulfan/etoposide/cyclophosphamide overcome the impact of pre-transplant minimal residual disease on outcomes in high-risk acute lymphoblastic leukemia patients in complete remission.

  • Authors : Zhao X; Department of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.; Xu Z

Subjects: Neoplasm, Residual* ; Precursor Cell Lymphoblastic Leukemia-Lymphoma*/Precursor Cell Lymphoblastic Leukemia-Lymphoma*/Precursor Cell Lymphoblastic Leukemia-Lymphoma*/therapy ; Precursor Cell Lymphoblastic Leukemia-Lymphoma*/Precursor Cell Lymphoblastic Leukemia-Lymphoma*/Precursor Cell Lymphoblastic Leukemia-Lymphoma*/mortality

  • Source: Cancer medicine [Cancer Med] 2024 Jan; Vol. 13 (1), pp. e6897. Date of Electronic Publication: 2024 Jan 02.Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

90 Y-Daclizumab (Anti-CD25), High-Dose Carmustine, Etoposide, Cytarabine, and Melphalan Chemotherapy and Autologous Hematopoietic Stem Cell Transplant Yielded Sustained Complete Remissions in 4 Patients with Recurrent Hodgkin's Lymphoma.

  • Authors : Conlon KC; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.; Sportes C

Subjects: Carmustine/Carmustine/Carmustine/*therapeutic use ; Cytarabine/Cytarabine/Cytarabine/*therapeutic use ; Daclizumab/Daclizumab/Daclizumab/*therapeutic use

  • Source: Cancer biotherapy & radiopharmaceuticals [Cancer Biother Radiopharm] 2020 May; Vol. 35 (4), pp. 249-261. Date of Electronic Publication: 2020 Apr 09.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 9605408 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

The combination of clofarabine, etoposide, and cyclophosphamide shows limited efficacy as a bridge to transplant for children with refractory acute leukemia: results of a monitored prospective study.

  • Authors : Toporski J; Department of Pediatrics, Section of Pediatric Oncology, Hematology, Immunology and Nephrology, Skåne University Hospital, Lund, Sweden.; Król L

Subjects: Hematopoietic Stem Cell Transplantation*/Hematopoietic Stem Cell Transplantation*/Hematopoietic Stem Cell Transplantation*/methods; Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Clofarabine/Clofarabine/Clofarabine/*therapeutic use

  • Source: Pediatric hematology and oncology [Pediatr Hematol Oncol] 2021 Apr; Vol. 38 (3), pp. 216-226. Date of Electronic Publication: 2020 Nov 05.Publisher: Informa Healthcare Country of Publication: England NLM ID: 8700164 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Busulfan, etoposide, cytarabine, and melphalan as a high-dose regimen for autologous stem cell transplantation in peripheral T-cell lymphomas.

  • Authors : Jo JC; Department of Hematology and Oncology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea.; Kim JS

Subjects: Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*administration & dosage ; Busulfan/Busulfan/Busulfan/*administration & dosage ; Cytarabine/Cytarabine/Cytarabine/*administration & dosage

  • Source: Annals of hematology [Ann Hematol] 2021 Jan; Vol. 100 (1), pp. 189-196. Date of Electronic Publication: 2020 Nov 17.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
  • 1-10 of  4,442 results for ""Etoposide""